Rendu Overview
- Founded
-
2007
- Status
-
Public
- Employees
-
314
- Stock Symbol
-
688193
- Share Price
-
$7.77
- (As of Thursday Closing)
Rendu General Information
Description
Shanghai Rendu Biotechnology Co Ltd provides solutions for accurate diagnosis, effective prevention and control, as well as personalized diagnosis and treatment of pathogens in the areas of reproduction, respiration, digestion, blood, food, and environmental safety.
Contact Information
Primary Industry
Biotechnology
Stock Exchange
SHG
Primary Office
- No. B, Building 15
- No. 528, Ruiqing Road, East District, Zhangjiang Hi-Tech Park
- Shanghai, 201201
- China
+86 021 0000 0000
Rendu Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.77 | $7.88 | $6.23 - $10.70 | $315M | 40M | 248K | $0.18 |
Rendu Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 133,775 | |||
| Revenue | 47,118 | 45,269 | 36,173 | 14,352 |
| EBITDA | 7,125 | 12,534 | 10,951 | 1,179 |
| Net Income | 5,668 | 10,007 | 8,884 | 541 |
| Total Assets | 152,476 | 59,398 | 47,570 | 26,736 |
| Total Debt | 1,136 | 626 | 588 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Rendu Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rendu Patents
Rendu Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200292565-A1 | Automated nucleic acid sample preparation, detection, and analysis system | Pending | 11-Oct-2017 | 0000000000 | |
| JP-2021508250-A | Automatic nucleic acid sample preparation, detection and analysis system | Pending | 11-Oct-2017 | 00000000000 | 0 |
Rendu Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jinliang Ju Ph.D | Chairman & Chief Scientific Officer & Founder |
Rendu Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jinliang Ju Ph.D | Rendu | Chairman & Chief Scientific Officer & Founder | 000 0000 |
| William Hu | Qiming Venture Partners | Board Member | 000 0000 |
Rendu Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
